Procurement Summary
Country : Germany
Summary : Glp Repeat Can Toxicity Study
Deadline : 21 Apr 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 64766457
Document Ref. No. : 156474-2022
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : EUR 240000
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Document Type: Contract Notice
Title: GLP Repeat Dose Toxicity Study
Reference Number: 2022mmä000001
Contract Type: Services
Estimated Value: 240000 - EUR
Description: The European HIV Vaccine Alliance (EHVA) is a large research consortium funded by the European Commission's H2020 program (http://www.ehv-a.eu/). One of the vaccine candidates developed by the consortium are two recombinant protein HIV envelope trimers (CONCV5-GT and CONCV5-KIKO), which are adjuvant with MPLA-L. The consortium seeks to cooperate with a correspondingly qualified job research organization (CRO) to carry out a GLP toxicity study.
We are considering carrying a GLP study for toxicity in repeated administration to New Zealand white rabbits or rats. Our plan is to start the study in the second quarter 2022. Enclosed you will find the statement of Work (SO) for the study. Based on this sketch, we ask you to submit a proposal including costing and schedule if you are interested.
73111000 - Research Laboratory Services
Authority Type: Body Governed by Pub ...
Documents
Tender Notice